Scholarlink

Background <p>Two studies were conducted to determine whether treatment with NexGard<sup>®</sup> Plus (NP), a combination of afoxolaner, moxidectin, and pyrantel, prevents transmission of <i>Borrelia burgdorferi</i> to dogs by naturally infected <i>Ixodes scapularis</i>.</p> Methods <p>For each study, 20 dogs were randomly assigned to two groups (<i>n</i> = 10/group): NP and negative control. Twenty-eight days post-treatment, each dog was infested with approximately 50 <i>I. scapularis</i> that had a 60% <i>B. burgdorferi</i> infection rate in study 1 and a 38.5% infection rate in study 2. Five days post-infestation, ticks were counted and removed. The <i>B. burgdorferi</i>-specific C6 antibody was tested for using the SNAP<sup>®</sup> 4Dx<sup>®</sup> test (IDEXX) and the Lyme Quant C6 test with serum collected before treatment and infestation and 21, 35, 49, 63, and 75&#xa0;days post-infestation. Skin biopsies were collected 76&#xa0;days post-infestation and quantitative polymerase chain reaction (qPCR) conducted to detect <i>B. burgdorferi</i> DNA.</p> Results <p>On the day of count and removal, no ticks were found on treated dogs, while control dogs had an average of 25.1 ticks in study 1 and 19.6 ticks in study 2, for efficacy of 100% (<i>P</i> ≤ 0.0001). All dogs were seronegative before infestation. The first dog in the control groups became seropositive 21&#xa0;days post-infestation in study 1 and 35&#xa0;days post-infestation in study 2 by the SNAP 4Dx test and by 21&#xa0;days post-infestation by the Lyme Quant C6 test in both studies. Ten of 10 dogs in the control group in both studies seroconverted by the end of the study. None of the skin biopsies from treated dogs were positive for <i>B. burgdorferi</i> DNA, while at least three of the four skin biopsies from each of the control dogs tested positive at the end of the studies. No clinical signs of Lyme disease were detected in any of the dogs.</p> Conclusions <p>The results of these studies indicate that NexGard<sup>®</sup> Plus administered at a dose close to the minimum recommended dose of 2.5&#xa0;mg/kg afoxolaner is effective 28&#xa0;days after a single treatment in the prevention of <i>B. burgdorferi</i> transmission from naturally infected <i>I. scapularis</i> ticks to dogs.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月21日

查看全文
  • Joseph Prullage,
  • Pascal Dumont,
  • Arathy Nair,
  • Manyun Liu,
  • Utami DiCosty,
  • Ricarda Süssenberger

摘要

Background

Two studies were conducted to determine whether treatment with NexGard® Plus (NP), a combination of afoxolaner, moxidectin, and pyrantel, prevents transmission of Borrelia burgdorferi to dogs by naturally infected Ixodes scapularis.

Methods

For each study, 20 dogs were randomly assigned to two groups (n = 10/group): NP and negative control. Twenty-eight days post-treatment, each dog was infested with approximately 50 I. scapularis that had a 60% B. burgdorferi infection rate in study 1 and a 38.5% infection rate in study 2. Five days post-infestation, ticks were counted and removed. The B. burgdorferi-specific C6 antibody was tested for using the SNAP® 4Dx® test (IDEXX) and the Lyme Quant C6 test with serum collected before treatment and infestation and 21, 35, 49, 63, and 75 days post-infestation. Skin biopsies were collected 76 days post-infestation and quantitative polymerase chain reaction (qPCR) conducted to detect B. burgdorferi DNA.

Results

On the day of count and removal, no ticks were found on treated dogs, while control dogs had an average of 25.1 ticks in study 1 and 19.6 ticks in study 2, for efficacy of 100% (P ≤ 0.0001). All dogs were seronegative before infestation. The first dog in the control groups became seropositive 21 days post-infestation in study 1 and 35 days post-infestation in study 2 by the SNAP 4Dx test and by 21 days post-infestation by the Lyme Quant C6 test in both studies. Ten of 10 dogs in the control group in both studies seroconverted by the end of the study. None of the skin biopsies from treated dogs were positive for B. burgdorferi DNA, while at least three of the four skin biopsies from each of the control dogs tested positive at the end of the studies. No clinical signs of Lyme disease were detected in any of the dogs.

Conclusions

The results of these studies indicate that NexGard® Plus administered at a dose close to the minimum recommended dose of 2.5 mg/kg afoxolaner is effective 28 days after a single treatment in the prevention of B. burgdorferi transmission from naturally infected I. scapularis ticks to dogs.

Graphical Abstract